4〔1〕 Pendus AM,Knauper V, Puente XS, et al.Identification and characterization of a novel human matrix metallopeoteinase with uniquestructural characteristics, chromosomal location and tissue distribution. J Biol Chem,1997,272:4 281.
5〔2〕 Cawston TE. Billington C. Metalloproteinase in the rheumatic diseases. J Pathol,1996,180:115.〔3〕 Hasty KA, Jeffrey JJ, Hibbs MS, et al. The collagen substrate specifity of humanneutrophil collagenase. J Biol Chem, 1987,262:1 048.
6〔4〕 Knauper V, Lopez-Otin C, Smith B, et al. Biochemical characterization of humancollagenase-3. J Biol Chem, 1996,271:1 544.
7〔5〕 Matrisian LM. Metalloproteinases and their inhibitor in matrix remodeling.Trends Genet, 1990,6:121.
8〔6〕 Shinmei M, Kikuchi T, Yamagishi M, et al. The role of interleukin-1 onproteoglycan metabolism of rabbit anulus fibrosus cells cultured in vitro. Sprine,1988,13: 1 294.
9〔7〕 Kang JD, Georgescu HI, McIntyre-Larkin L, et al. Herniated lumbar intervertebraldiscs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6 andprostaglandin E2. Spine,1996,21:271.
10〔8〕 Liu J, Roughley PJ, Mort JS. Identification of human intervertebral discsstromelysin and its involvement in matrix degradation. J Orthop Rse, 1991,9:568.
